Natural presence of NS3 protease R155K hepatitis C virus variants with decreased sensitivity to protease inhibitors

Journal of Clinical Virology

Volumn 53, Issue 2, 2012, Pages 178-180

  Colson, Philippe ^a,b   Purgus, Raj ^b   Borentain, Patrick ^c   Gérolami, René ^c  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Antiviral therapy; Genotypic resistance; Hepatitis c virus; Natural resistance; NS3 protease inhibitors; R155K mutation

Indexed keywords

ANTIRETROVIRUS AGENT; BOCEPREVIR; NONSTRUCTURAL PROTEIN 3; SERINE PROTEINASE INHIBITOR; TELAPREVIR;

AMINO ACID SUBSTITUTION; GENE MUTATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; LETTER; NEPHROTIC SYNDROME; PHYLOGENY; PRIORITY JOURNAL; VIRUS STRAIN;

DRUG RESISTANCE, VIRAL; GENETIC VARIATION; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; MUTATION; PROTEASE INHIBITORS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84855538297     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.10.005     Document Type: Letter

References (5)

1. Sarrazin C., Zeuzem S. Resistance to direct antiviral agents in patients with hepatitis C virus infection. Gastroenterology 2010, 138(2):447-462.
2. Bartels D.J., Zhou Y., Zhang E.Z., Marcial M., Byrn R.A., Pfeiffer T., et al. Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naive subjects. J Infect Dis 2008, 198(6):800-807.
3. López-Labrador F.X., Moya A., Gonzàlez-Candelas F. Mapping natural polymorphisms of hepatitis C virus NS3/4A protease and antiviral resistance to inhibitors in worldwide isolates. Antivir Ther 2008, 13(4):481-494.
4. Colson P., Gérolami R. Two years' persistence of naturally present substitution R155K within hepatitis C virus NS3 protease in the absence of protease inhibitor-based therapy. J Infect Dis 2011, 203(9):1341-1342.
5. Thompson M.A., Aberg J.A., Cahn P., Montaner J.S., Rizzardini G., Telenti A., et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA 2010, 304(3):321-333.